Autres langues GSK plc NYSE

Actions

GSK

US37733W2044

Produits pharmaceutiques

Marché Fermé - NYSE Autres places de cotation 22:00:02 11/08/2026			Pré-ouverture 13:49:04
50,90 ^USD	-2,42%		50,58	-0,63%

12:02	L'objectif de Trump de diviser le vaccin ROR pourrait prendre une décennie, selon les experts	RE
10:21	PALMARÈS : La distribution pénalisée par les craintes de sécheresse ; Balfour relève ses prévisions	AN

Autres langues

12:02	Trump's goal to split MMR vaccine could take a decade, experts say
10:21	WINNERS & LOSERS: Grocers down on drought worries; Balfour ups outlook
11/08	Global drugmakers invest billions to boost US presence
11/08	Trump streicht Empfehlungen für Kinderimpfungen zusammen
10/08	WINNERS & LOSERS: Threat to Vistry; Plus500 plans more share buybacks
06/08	LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors
06/08	US FDA approves first mRNA flu shot from Moderna
04/08	Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says
04/08	ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future
03/08	GSK India first-quarter profit rises on steady vaccine demand
03/08	RBC cuts JD Sports; Jefferies cuts Severn Trent
30/07	Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US
30/07	GSK global supply chain director sells 38,000 shares
30/07	GSK, Relation Therapeutics to Collaborate on Human Cellular Perturbation Data
30/07	GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal
30/07	WINNERS & LOSERS: Rolls-Royce ups guide; Rentokil slumps
30/07	Relation Therapeutics Limited and Glaxosmithkline plc Announce Expanded Collaboration to Generate Large-Scale Human Cellular Perturbation Datasets
30/07	Berenberg raises Rio Tinto; HSBC ups Centrica
30/07	GSK, Relation Therapeutics Collaborate on Human Cellular Data Project
30/07	Goldman Sachs still cautious about GSK
29/07	GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment
28/07	GSK plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
28/07	Gsk plc Declares Second Interim Dividend for the Second Quarter of 2026, Payable on 8 October 2026
28/07	GSK plc : Another beat; we appreciate the new CEO's aggressive intent
28/07	Behauptet - Berichtssaison gibt den Takt vor